Imugene Liabilities And Stockholders Equity from 2010 to 2024
| IMU Stock | 0.04 0 2.70% |
Liabilities And Stockholders Equity | First Reported 1997-06-30 | Previous Quarter 230.4 M | Current Value 151.4 M | Quarterly Volatility 67 M |
Check Imugene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Imugene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 502.3 K or Other Operating Expenses of 148 M, as well as many indicators such as . Imugene financial statements analysis is a perfect complement when working with Imugene Valuation or Volatility modules.
Imugene | Liabilities And Stockholders Equity |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imugene Stock Analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.